# Medical Cannabis in Patients With Advanced Pancreatic and Colorectal Cancer

> **NCT06605430** · PHASE2 · RECRUITING · sponsor: **HealthPartners Institute** · enrollment: 64 (estimated)

## Conditions studied

- Pancreatic Cancer Non-resectable
- Pancreatic Cancer Metastatic
- Colorectal Cancer Metastatic

## Interventions

- **DRUG:** Medical Cannabis

## Key facts

- **NCT ID:** NCT06605430
- **Lead sponsor:** HealthPartners Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-16
- **Primary completion:** 2026-09
- **Final completion:** 2026-12
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2025-07-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06605430

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06605430, "Medical Cannabis in Patients With Advanced Pancreatic and Colorectal Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06605430. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*